Table 3.
Adjusted Prevalence of Receiving Screenings for Breast, Cervical and Colorectal Cancers Within the Recommended Intervals in Women with and Without Diabetes, and the Odds Ratios for Receiving These Screenings in Women with Diabetes Using Women Without Diabetes as the Referent, BRFSS 2006
| Cancer screening | Age group | Adjusted* prevalence (SE) | Odd ratios (95% CI) | ||
|---|---|---|---|---|---|
| Diabetes | No diabetes | Unadjusted | Adjusted* | ||
| Breast cancer | ≥40 years | 76.4 (0.7) | 77.1 (0.2) | 1.09 (1.00-1.18) | 0.96 (0.87-1.05) |
| Cervical cancer | 18-<70 years | 74.2 (0.8)† | 79.0 (0.2) | 0.65 (0.60-0.71) | 0.73 (0.66-0.81) |
| Colorectal cancer | ≥50 years | 63.2 (0.9)‡ | 60.4 (0.3) | 1.15 (1.06-1.25) | 1.14 (1.04-1.24) |
| Fecal occult blood test | ≥50 years | 18.3 (0.6)† | 15.5 (0.2) | 1.27 (1.15-1.40) | 1.24 (1.12-1.36) |
| Sigmoidoscopy/ colonoscopy | ≥50 years | 57.0 (0.9) | 55.8 (0.3) | 1.06 (0.98-1.15) | 1.05 (0.97-1.14) |
*Adjusted for age, body mass index, race/ethnicity, education, marital status, current smoking, health insurance and a routine checkup visit. †P < 0.001 and ‡P < 0.01 for comparisons between women with diabetes and those without. BRFSS: Behavioral Risk Factor Surveillance System; CI: confidence interval; SE: standard error